QD Syringe ................................................
"Multi-Purpose Reconstitution Syringe"

Coming 2011!

AnestaWeb, Inc. Medical Division - 2011
*
®

QD Syringe

QD Syringe is used in Customized Procedure Kits for the Emergency and Health Care industries where bedside medication reconstitution is necessary.

TM
QD Syringe
TM
Lyophilization should be considered for all solid actives that are either sensitive to heat or which are chemically or biologically unstable, or when solutions are suspected to interact unfavorably with the vial or package.

Although the principal change in lyophilization is water removal, the objective of freeze-drying pharmaceuticals is product stabilization. Lyophilization imparts higher stability, broader temperature tolerance, and longer shelf-life to most pharmaceutical formulations that are unstable in aqueous solution.
Lyophilization is growing approximately as rapidly as biotechnology, although non-biotech products can also benefit. Candidates for lyophilization include injectable solutions, proteins, peptides, and vaccines.

The number of such products has been growing steadily: 370 biotechnology products are currently in development, with more than 300 sterile product approvals expected between 2005 and 2012. Approximately 25% of these products will be lyophilized.
The market for lyophilized products is expected to reach up to 151 million units annually by 2010. This growth will be driven primarily by the introduction of new products, specifically biologics such as monoclonal antibodies (Mabs) and recombinant proteins.

It is expected that 40% of the injectable NME's approved in the next five years will require lyophilization. According to a recent survey by Pharmsource, about 75% of the overall lyophilization capacity is committed through 2008.

It should be pointed out that for many products, including the vast majority of high-value proteins, peptides, and vaccines, lyophilization is the only way to deliver stable, biologically active products with long shelf-life.
There is an increased demand from pharmaceutical companies for lyophilization manufacturing services as there is an increased recognition of this process' benefits. With the growing number of drugs in development, lyophilization becomes a logical, time-effective, and cost-sensitive option.
WHAT ARE LYOPHILISED DRUGS?